Skip to content

Enovis ENOV Acquisitions

Acquisitions at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.04B+304,000%
Stryker logo
StrykerSYK
$22M-99.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$166.9M+4.3%
Globus Medical logo
Globus MedicalGMED
$4.91M-1.8%
Avanos Medical logo
Avanos MedicalAVNS
$3.4M+41.7%
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$0-100%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's acquisitions?
Enovis (ENOV) reported acquisitions of $291K in Q1 2026.
How has Enovis's acquisitions changed year-over-year?
Enovis's acquisitions decreased by 98.5% year-over-year, from $18.86M to $291K.
What is the long-term trend for Enovis's acquisitions?
Over 4 years (2021 to 2025), Enovis's acquisitions has grown at a -41.6% compound annual growth rate (CAGR), from $230.96M to $26.86M.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.